US$ 23.27
what are some glp-1 drugs Agonists Explained: Definition, How They Work, Side Effects GLP-1 Drugs & What They
Description
What we don't know yet Two honest caveats

"The potential benefit is real, and it makes biological sense," Gilberto de Lima Lopes, chief of medical oncology at the Sylvester Comprehensive Cancer Center at the University of Miami, told The Washington Post

However, compulsive sexual behaviors increased in some users

An important question to ask, and one we may never have a clear answer to, is what amount of residual gastric contents increases the risk of aspiration? Surely, type of gastric contents (liquid or solid) also matters

Tirzepatide (Zepbound) : SURMOUNT-1/-2 trials show 15%22% average weight loss at 72 weeks, depending on dose and whether participants had diabetes

The conversion guidance that exists for transitioning between other GLP-1 agonists can provide some framework for thinking about dosing during transitions, though no specific tirzepatide-to-retatrutide conversion protocol has been established in clinical literature
